This inventor holds 3 USPTO granted patents. Top assignees: Chemische Werke Huls Aktiengesellschaft, Other. Active years: 1980-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gladbeck, DE (1980 - 1982)
- 23627 Groβ-Sarau, DE (2010)
Company Filing History:
Years Active: 1980-2010
Title: Klaus M Diedrich: Innovator in Therapeutic Management and Polymer Chemistry
Introduction
Klaus M Diedrich is a notable inventor based in Gladbeck, Germany. He has made significant contributions to the fields of therapeutic management and polymer chemistry. With a total of 3 patents, his work has had a meaningful impact on medical treatments and material science.
Latest Patents
One of Diedrich's latest patents is a method for the therapeutic management of endometriosis. This invention provides a method for managing extrauterine proliferation of endometrial tissue, chronic pelvic pain, and fallopian tube obstruction through short-term induction treatment with an LH-RH antagonist for 4 to 12 weeks. The treatment can be followed by the administration of one or more active agents, including contraceptives, non-steroidal anti-rheumatic agents, analgesics, and androgens. Another significant patent involves copolymers containing hydroxyl groups, which are derived from maleic anhydride and dicyclopentadiene. This copolymer is particularly useful for the sizing of paper.
Career Highlights
Throughout his career, Klaus M Diedrich has worked with various companies, including Chemische Werke Huls Aktiengesellschaft. His innovative approaches have led to advancements in both therapeutic methods and polymer applications.
Collaborations
Diedrich has collaborated with notable coworkers such as Felix Schulde and Karl Peterlein. Their combined expertise has contributed to the success of his inventions.
Conclusion
Klaus M Diedrich's contributions to innovation in therapeutic management and polymer chemistry highlight his role as a significant inventor. His patents reflect a commitment to improving medical treatments and material applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile